217 related articles for article (PubMed ID: 12610509)
1. Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma.
Yokoyama Y; Charnock-Jones DS; Licence D; Yanaihara A; Hastings JM; Holland CM; Emoto M; Umemoto M; Sakamoto T; Sato S; Mizunuma H; Smith SK
Br J Cancer; 2003 Jan; 88(2):237-44. PubMed ID: 12610509
[TBL] [Abstract][Full Text] [Related]
2. [Lymphatic metastasis and VEGF-C expression in ovarian epithelial tumors].
Ding MX; Li JC; Tang XH
Shi Yan Sheng Wu Xue Bao; 2003 Dec; 36(6):445-52. PubMed ID: 14724935
[TBL] [Abstract][Full Text] [Related]
3. Expression of vascular endothelial growth factor (VEGF)-D and its receptor, VEGF receptor 3, as a prognostic factor in endometrial carcinoma.
Yokoyama Y; Charnock-Jones DS; Licence D; Yanaihara A; Hastings JM; Holland CM; Emoto M; Sakamoto A; Sakamoto T; Maruyama H; Sato S; Mizunuma H; Smith SK
Clin Cancer Res; 2003 Apr; 9(4):1361-9. PubMed ID: 12684405
[TBL] [Abstract][Full Text] [Related]
4. Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer.
Sopo M; Anttila M; Hämäläinen K; Kivelä A; Ylä-Herttuala S; Kosma VM; Keski-Nisula L; Sallinen H
BMC Cancer; 2019 Jun; 19(1):584. PubMed ID: 31200683
[TBL] [Abstract][Full Text] [Related]
5. Explorative investigation of vascular endothelial growth factor receptor expression in primary ovarian cancer and its clinical relevance.
Wimberger P; Chebouti I; Kasimir-Bauer S; Lachmann R; Kuhlisch E; Kimmig R; Süleyman E; Kuhlmann JD
Gynecol Oncol; 2014 Jun; 133(3):467-72. PubMed ID: 24713547
[TBL] [Abstract][Full Text] [Related]
6. Over-Expression of TBL1XR1 Indicates Poor Prognosis of Serous Epithelial Ovarian Cancer.
Ma M; Yu N
Tohoku J Exp Med; 2017 Mar; 241(3):239-247. PubMed ID: 28344213
[TBL] [Abstract][Full Text] [Related]
7. Expression of VEGF-D in epithelial ovarian cancer and its relationship to lymphatic metastasis.
He L; He J; Zhao X
Asia Pac J Clin Oncol; 2016 Mar; 12(1):e161-6. PubMed ID: 23915006
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma.
Jüttner S; Wissmann C; Jöns T; Vieth M; Hertel J; Gretschel S; Schlag PM; Kemmner W; Höcker M
J Clin Oncol; 2006 Jan; 24(2):228-40. PubMed ID: 16344322
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions.
Davidson B; Reich R; Kopolovic J; Berner A; Nesland JM; Kristensen GB; Tropé CG; Bryne M; Risberg B; van de Putte G; Goldberg I
Clin Exp Metastasis; 2002; 19(2):135-44. PubMed ID: 11964077
[TBL] [Abstract][Full Text] [Related]
10. Podocalyxin-like protein 1 expression and correlation with clinical characteristics in epithelial serous and mucinous ovarian carcinoma and tumor-like lesions.
Ye F; Hu Y; Zhou C; Hu Y; Chen H
Pathobiology; 2012; 79(6):307-13. PubMed ID: 22688257
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.
Arinaga M; Noguchi T; Takeno S; Chujo M; Miura T; Uchida Y
Cancer; 2003 Jan; 97(2):457-64. PubMed ID: 12518370
[TBL] [Abstract][Full Text] [Related]
12. The Application Value of HNF-1β Transcription Factor in the Diagnosis of Ovarian Clear Cell Carcinoma.
Huang W; Cheng X; Ji J; Zhang J; Li Q
Int J Gynecol Pathol; 2016 Jan; 35(1):66-71. PubMed ID: 26166716
[TBL] [Abstract][Full Text] [Related]
13. Nuclear receptor DAX-1 in human common epithelial ovarian carcinoma: an independent prognostic factor of clinical outcome.
Abd-Elaziz M; Akahira J; Moriya T; Suzuki T; Yaegashi N; Sasano H
Cancer Sci; 2003 Nov; 94(11):980-5. PubMed ID: 14611675
[TBL] [Abstract][Full Text] [Related]
14. VEGF, VEGFR-1, VEGFR-2, microvessel density and endothelial cell proliferation in tumours of the ovary.
Orre M; Rogers PA
Int J Cancer; 1999 Apr; 84(2):101-8. PubMed ID: 10096239
[TBL] [Abstract][Full Text] [Related]
15. The role and prognostic value of inducible nitric oxide synthase (iNOS) and interleukin-33 (IL-33) in serous and mucinous epithelial ovarian tumours.
Saied EM; El-Etreby NM
Ann Diagn Pathol; 2017 Apr; 27():62-68. PubMed ID: 28325363
[TBL] [Abstract][Full Text] [Related]
16. Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels.
Yamamoto S; Konishi I; Mandai M; Kuroda H; Komatsu T; Nanbu K; Sakahara H; Mori T
Br J Cancer; 1997; 76(9):1221-7. PubMed ID: 9365173
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of IL-8 and IL-8 receptors in benign, borderline and malignant ovarian epithelial tumours.
Browne A; Sriraksa R; Guney T; Rama N; Van Noorden S; Curry E; Gabra H; Stronach E; El-Bahrawy M
Cytokine; 2013 Oct; 64(1):413-21. PubMed ID: 23727325
[TBL] [Abstract][Full Text] [Related]
18. EphA8 is a prognostic marker for epithelial ovarian cancer.
Liu X; Xu Y; Jin Q; Wang W; Zhang S; Wang X; Zhang Y; Xu X; Huang J
Oncotarget; 2016 Apr; 7(15):20801-9. PubMed ID: 26989075
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma.
Nishida N; Yano H; Komai K; Nishida T; Kamura T; Kojiro M
Cancer; 2004 Sep; 101(6):1364-74. PubMed ID: 15368324
[TBL] [Abstract][Full Text] [Related]
20. The effect of the expression of vascular endothelial growth factor (VEGF)-C and VEGF receptor-3 on the clinical outcome in patients with gastric carcinoma.
Han FH; Li HM; Zheng DH; He YL; Zhan WH
Eur J Surg Oncol; 2010 Dec; 36(12):1172-9. PubMed ID: 20888167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
